Allergan Lumigan is guaranteed safe as the Food and Drug Administration or FDA has already issued an approval so that this drug can penetrate with factual and clinical supports. Lumigan is an eye drop medication prescribed to be taken once a day. It contains 0.03 percent ophthalmic solution which was recognized as an effective treatment for ocular hypertension and open-angle glaucoma.
Allergan is a prominent manufacturer of drugs. It has been 55 years or more that the company has continuously ventured on their expertise for formulating top quality and science-based medicines. Allergan, Inc. has different headquarters distributed in the different areas of Irvine, California. There is no doubt that Allergan has managed to prove their worth in commercializing drugs in ophthalmology, medical aesthetics, medical dermatology, and neurosciences.
Quoting the statement of Allergan’s Executive VP, Research and Development, Mr. Scott Whitcupp: “We are pleased to offer eye care professionals this effective therapy to treat elevated IOP in their glaucoma patients at any point in the course of the disease”. Scott’s statement opened bigger anticipations to doctors and patients. And for years now, many experts and users were satisfied with the works and performances of Lumigan.
The announcement of FDA approval for Lumigan was officially made on year 2001. Lumigan was tested to work in reducing the IOP. For years now, this Allergan’s medicine has been a popular prescription of doctors, to lessen the heightened IOP. The increase of IOP is harmful to any individual since it can trigger possibilities of vision loss incorporated with glaucoma. Glaucoma is actually one of the most common conditions. It actually exists to over 3 million individuals residing in the US and roughly 67 million worldwide. Thus, the development of Lumigan has become an ultimate help.
The use of Allergan Lumigan may lead to some side effects. Pigmented tissues may change. A dominant pigmentation occurs in the augmentation of iris pigmentation. Furthermore, Lumigan was also found out to affect the periorbital eyelid as well the eyelashes. It also affects the growth of lashes, stimulating it so it can grow longer than the usual. It is assumed that pigmentation will continue to boost, unless the application of Lumigan is stopped.
Once the application of Lumigan is stopped, there is a possibility that the development of iris pigmentation will be permanent. Pigmentation on the eyelashes and periorbital tissue can be reversed once the medication is stopped. Patients must then be made aware about the basics of Lumigan application. Similar to other kinds of medicines, Lumigan may cause side effects and these are the things that you must put into consideration.
Professor Paul Lee of Duke University commented that Lumigan facilitates the validation of the medicinal lipid class. It turned to be a constant treatment for high IOP. In fact, the one-day lipids are turning to be an ideal therapy chosen by most patients because of its systematic safety and efficacy. Lee’s feedback is factual and was based through observation and medical analysis. Lumigan is still an amazing product, with proper analysis and application.